Daix (France), Long Island City (New York, United States), March 1, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a biopharmaceutical company specializing in the clinical development of small molecules administered orally for the treatment of nonalcoholic steatohepatitis (NASH) and other diseases with unmet medical need, today announces that its management team will participate in two investor conferences during the month of March 2022.
The event details are as follows:
Conference n°1: “Cowen 42nd Annual Health Care Conference”
Type of event: Company presentation and investor meeting
Date: Monday-Wednesday, March 7-9, 2022
Inventiva Presentation: Monday, March 7, 12:50 p.m. – 1:20 p.m. (Eastern time) / 6:50 p.m. – 7:20 p.m. (Paris time)
Format: Virtual event
Link (live & replay): https://wsw.com/webcast/cowen108/iva/1843488